Resources & References
Below are links to key primary and official sources related to Retatrutide. These are provided for educational purposes so readers can explore the original data themselves.
Official Eli Lilly Announcements
Clinical Trial Registry
- ClinicalTrials.gov – Search for Retatrutide (LY3437943) (opens in new tab)
Additional Context
- Eli Lilly investor relations and pipeline information pages (search “retatrutide” on investor.lilly.com)
- Peer-reviewed publications from earlier phase studies (available via PubMed or NEJM for the Phase 2 obesity trial)
Note on External Links Retatrutide 10mg Info provides these links as a convenience. We are not responsible for the content, accuracy, or availability of external websites. Always verify information directly from the source.
We recommend starting with the official Lilly press releases and ClinicalTrials.gov for the most authoritative and up-to-date information.
Last reviewed: June 27, 2026
Important: This is educational information only. Retatrutide is investigational and not approved. This is not medical advice. Consult a qualified healthcare professional.